Effects of Saxagliptin on Endothelial Function in Patients With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 19 Sep 2014
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ESENDI
- 10 Jun 2017 Biomarkers information updated
- 09 Jul 2012 NCT reports Status as Recruiting and Actual Initiation Date is 1 Oct 2010.
- 26 May 2012 Actual end date (4 Apr 2012) added as reported by European Clinical Trials Database record.